Table 5 Sensitivity Analysis: Estimated Incremental Cost Effectiveness Ratio in Study Groups
| Â | Tele-BA vs. AC | Tele-PST vs. AC | Tele-BA vs. Tele-PST |
|---|---|---|---|
| Â | Mean Difference | Mean Difference | Mean Difference |
1) Adjusted for age effect | |||
Incremental cost | -$2,897.77 | -$8,149.94 | $5,252.17 |
QALY 1 | 0.0608 | 0.0329 | 0.0279 |
ICER 2 | -$47,660.62 | -$247,718.54 | $188,249.98 |
2) Participants with at least one follow-up data (N = 260) | |||
Incremental Cost | -$3,825.29 | -$7,723.00 | $3,897.51 |
QALY | 0.0585 | 0.0226 | 0.0359 |
ICER | -$65,390 | -$341,726 | $108,571 |
3) Participants with complete data (N = 222 3 ) |  | ||
Incremental Cost | -$7,473.19 | -$9,842.03 | $2,368.84 |
QALY | 0.0746 | 0.0217 | 0.0529 |
ICER | -$100,177 | -$453,550 | $44,780 |
4) Using MEPS 4 unit cost for Medicare beneficiaries aged 50+ | |||
Incremental Cost | -$3,078.54 | -$9,842.03 | $2,368.84 |
QALY | 0.0614 | 0.0279 | 0.0335 |
ICER | -$50,144 | -$240,671 | $108,534 |
5) Using MEPS unit cost for Medicare and Medicaid dual beneficiaries aged 50+ | |||
Incremental Cost | -$2,849.42 | -$6,214.74 | $3,365.32 |
QALY | 0.0614 | 0.0279 | 0.0335 |
ICER | -$46,407 | -$222,751 | $100,457 |
6) Using MEPS unit cost for all those aged 50+ | Â | ||
Incremental Cost | -$6,624.95 | -$11,393.69 | $4,768.74 |
QALY | 0.0614 | 0.0279 | 0.0335 |
ICER | -$107,898 | -$408,376 | $142,350 |